Abstract
There is limited data available regarding the clinical utility of routine molecular diagnosis of β Thalassaemia in addition to HPLC-based screening in low resource settings. The current study highlights the caveats of an HPLC-based screening compared to the inclusion of genetic confirmation as a second-tier test and its implications in terms of genotype-phenotype correlation. A prospective, institution-based, observational study was conducted at the Department of Paediatric Medicine, including 103 children aged up to 12 years. Five common mutations for β Thalassemia and the HbE mutation in the HBB gene were tested by a two-tiered approach using multiplex ARMS PCR and PCR RFLP methods respectively. Sanger sequencing of all three exons of the HBB gene was performed in all negative cases. Sequencing revealed many rare pathogenic mutations like c.316-106 C > G (dbSNP: 34,690,599); Hb Kairouan (c.92G > C); c.33 C > A (dbSNP rs35799536); c.47G > A (dbSNP rs63750783); c.51delC (HbVar ID 799); c.[93-2 A > C] and c.118 C > T (HbVar ID 845). We detected a novel Pathogenic M_000518.5(HBB):c.164_168delinsGGCATCA (p.Val55fs) mutation in a heterozygous state which was reported in the ClinVar database with accession ID VCV000590977.2. We also encountered several cases of silent carrier on HPLC and de novo occurrence of mutation. We conclude that the multiplex touchdown ARMS PCR methodology employed in the present study provides a low-cost solution for molecular diagnostics of Β Thalassaemia. The problem of silent carriers in HPLC is significant enough to rethink if we need supplemental genetic testing in the couple when one of the partners is a carrier.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Colah R, Italia K, Gorakshakar A. Burden of thalassemia in India: The road map for control. Pediatr Hematol Oncol J. 2017;2(4):79–84.
Grow K, Vashist M, Abrol P, Sharma S, Yadav R. Beta thalassemia in india: Current status and the challenges ahead. Int. J. Pharm. Pharm. Sci. 20141;6:28–33.
Verma IC, Saxena R, Thomas E, Jain PK. Regional distribution of β-thalassemia mutations in India. Hum. Genet. 199;100(1):109–13.
Gupta A, Hattori Y, Gupta UR, Sarwai S, Nigam N, Singhal P, et al. Molecular Genetic Testing of β-Thalassemia Patients of Indian Origin and a Novel 8-bp Deletion Mutation at Codons 36/37/38/39. Genet Test. 2003;7(2):163–8.
Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of β-thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol. 1991;78(2):242–7.
Bhattacharyya DM, Mukhopadhyay A, Basak J. Descriptive profile of β-thalassemia mutations in West Bengal population: a hospital-based study. Int J Hematol. 2014;99(3):345–53.
Colah R, Nadkarni A, Gorakshakar A, Phanasgaonkar S, Surve R, Subramaniam PG, et al. Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India. Blood Cells Mol Dis. 2004;33(2):153–7.
Ho H, Luo, Weatherall T. Beta-thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? Br J Haematol. 1998;100(1):70–8.
Nadkarni A, Gorakshakar AC, Lu CY, Krishnamoorthy R, Ghosh K, Colah R, et al. Molecular pathogenesis and clinical variability of Beta thalassemia syndromes among Indians. Am J Hematol. 2001;68(2):75–80.
Panigrahi I, Marwaha R. Mutational spectrum of thalassemias in India. Indian J Hum Genet. 2007;13(1):36.
Sahu PK, Pati SS, Mishra SK. Genotype-Phenotype Correlation of β-Thalassemia Spectrum of Mutations in an Indian Population. Hematol Rep 2012;4(2):e9.
Bhardwaj U, Zhang YH, Lorey F, McCabe LL, McCabe ERB. Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, Southeast Asian, and Chinese Beta-thalassemia mutations. Am J Hematol. 2005;78(4):249–55.
Acknowledgements
Professor (Dr.) Avijit Hazra, Dept of Pharmacology for helping with the statistical analysis. Patients and their Parents for their continuous co-operation.
Funding
Not applicable.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
Institutional ethics committee had approved the current work.
Informed Consent
All children were included in this study after obtaining written informed consent from their legal guardians.
Consent for Publication
All children were included in this study after obtaining written informed consent from their legal guardians regarding publication of the findings of the study without disclosing their identity.
Conflict of Interest
The authors declare no conflict of interest relevant to this study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sinha, S., Dutta, A.K., Bhattacharya, P. et al. Spectrum of Rare and Novel Indel Mutations Responsible for β Thalassemia in Eastern India. Ind J Clin Biochem 39, 207–213 (2024). https://doi.org/10.1007/s12291-022-01098-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-022-01098-w